Media Thread, page-10516

Thansk@GMT2.

Everyone should watch this...
But just a summary...

Consider the following...
1. Some of the patients had been on 6 (that's right 6) different drugs before this trial (including checkpoints/chemo/Keytruda (perhaps). Can you imagine, what that would do to your immune system and yet still have a response.
2. One that was cured was on Mono-therapy - so CF33 alone.
3. Data is cut in time - so it will only mature - that is it will get better.
4. Doctors are throwing their patients at this study, voting on their feet and desperate to get patients into this. People have suggested, where is the news on this... but the people that matter know about it and going for it. Enrolling v fast.
5. We only at a mid level dose, still a big dose to go. We keep going up the dose.

Can you imagine getting this as a. first line of therapy, b. at a higher dose, and as a mono-therapy, with any solid tumour!

This is w/o even considering Azer-Cel and the possibilities in 2024.